Bhageria Industries Ltd Q2 FY26 | When a Dye-Maker Decides to Go Solar (and Accidentally Starts Doing Pharma Too)
(Because who doesn’t like a little diversification chaos with their acid production?)
1. At a Glance
Picture this: a ₹754 crore small-cap that makes dyes, sells power, and now dreams of APIs. Bhageria Industries Ltd (BIL), the veteran dye-intermediate player from 1989, posted a fiery Q2 FY26 — Revenue ₹204 crore, PAT ₹11.8 crore, YoY profit up 80%, and an EPS of ₹2.70. The market didn’t throw a party, though — the stock slouched around ₹173, nursing a 13% quarterly hangover.
With an ROE of 6.35%, ROCE of 8.07%, and EV/EBITDA at 7.8x, this one’s like that classmate who does okay in every subject but never cracks the merit list. Dividend yield? 0.87%. Solar capacity? 33.8 MW, including the one that caught fire last May (insured, don’t worry).
And as if making dye intermediates like Vinyl Sulphone and H-Acid wasn’t colorful enough, Bhageria’s planning to enter the pharma ingredients game by FY26 — because, clearly, India’s dye makers think the cure for boredom is Vitamin B12 derivatives.
2. Introduction
Once upon a time, Bhageria Industries was just a humble dye-intermediate manufacturer from Mumbai’s industrial sprawl — an OHSAS, ISO, and alphabet-soup-certified chemical outfit. Then came solar plants, Bahrain subsidiaries, fire accidents, SEBI orders, and now, Vitamin B12 dreams.
In the small-cap universe, diversification is often code for “We ran out of ideas in the core business.” But in Bhageria’s case, it’s more like “We’re going to paint every industry with the same acid brush.”
The company’s Q2 FY26 numbers brought some relief: sales shot up 58% YoY, and profits nearly doubled, suggesting that someone finally remembered to turn on the solar panels and the cost controls. Yet, the five-year track record is sobering — sales growth just 7.5%, and profit growth negative.
Still, this ₹173-a-share underdog refuses to die. It quietly holds 71.8% promoter stake, a 2.7x current ratio, and debt barely worth gossiping about (D/E 0.13). It’s stable, clean, and conservative — like a Gujarati father who still calls WhatsApp “what’s up app.”
3. Business Model – WTF Do They Even Do?
Let’s break this down. Bhageria’s business has two main heads: 1. Chemicals (≈94% of revenue) – They make dyes and intermediates like H-acid, J-acid, Tobias acid, and Vinyl Sulphone — basically the ingredients that go into coloring your jeans, plastics, and every Holi outfit you regret buying. 2. Solar Power (≈6%) – They own ~33.8 MW of solar capacity, with 25-year PPAs at tariffs ranging from ₹4.4 to ₹6.6/unit. Translation: they sell sunlight for money, but it’s not their day job.
Backward integration: They even produce their own sulfuric acid (300 TPD) because when your raw materials are corrosive, you might as well make them yourself.
Upcoming business: They’re now entering the pharma raw material (API) segment — specifically Vitamin B12 derivatives — at a ₹50 crore capex funded internally. When this is complete (expected March 2025), Bhageria might be the only company where your multivitamin and your shirt dye share the same origin story.
Key clients: Huntsman, Everlight Chemical, and others who apparently trust Bhageria’s chemistry more than their own R&D teams.
Export mix: ~10%, mainly to South Korea, China, Thailand, and Spain — because color has no borders.
So yes, Bhageria makes dyes, burns the sun, and now wants to make drugs. How’s that for vertical integration?
Commentary: Imagine an industrial plant that finally finds its calculator. Bhageria’s YoY growth looks sexy, but before you pop champagne, note that FY23 was dismal — a low base always flatters recovery. Still, that EBITDA margin at 11% is an improvement from the single-digit struggles of the pandemic era.
5. Valuation Discussion – Fair Value Range (Educational)
Let’s run the three classic valuation toys:
(a) P/E Method Annualised EPS = ₹10.8 Industry P/E (Dyes & Pigments) ≈ 19x Apply 20% discount for Bhageria’s small-cap volatility → 15.2x Fair Value Range (P/E): ₹163 – ₹195
